GenevieveM.BolandMDPhD
General Surgery • Boston, MASurgical Oncology (Other than Breast)
Surgical Oncology at MGH
Dr. Boland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
# 7B
Boston, MA 02114Phone+1 617-726-8290
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2011 - 2014
Massachusetts General HospitalResidency, Surgery, 2006 - 2011
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2006
Certifications & Licensure
ME State Medical License 2020 - 2026
MA State Medical License 2014 - 2025
NH State Medical License 2024 - 2024
TX State Medical License 2011 - 2015- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture.Daniel C Rabe, Adarsh Choudhury, Dasol Lee, Evelyn G Luciani, Uyen K Ho
Science Advances. 2025-01-10 - TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids.Yi Sun, Luke Maggs, Apekshya Panda, Samuel J Wright, Angelina M Cicerchia
Cancer Immunology Research. 2025-01-09 - Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparapvec: A Single-Institution Retrospective Analysis.Kailan Sierra-Davidson, Aikaterini Dedeilia, Aleigha Lawless, Tanya Sharova, Howard L Kaufman
Annals of Surgical Oncology. 2025-01-01
Journal Articles
- Publisher Correction: Robust Prediction of Response to Immune Checkpoint Blockade Therapy in Metastatic MelanomaGenevieve Boland, Ryan J Sullivan, Keith Flaherty, Nature
- Robust Prediction of Response to Immune Checkpoint Blockade Therapy in Metastatic MelanomaRyan J Sullivan, Genevieve Boland, Keith Flaherty, Nature
Press Mentions
Revolutionary Ultrasensitive Test Tracks Intact Virus Levels in COVID-19 Patients over TimeJanuary 22nd, 2025- Ultrasensitive Test Detects and Serially Monitors Intact Virus Levels in COVID-19 PatientsJanuary 22nd, 2025
- Ultrasensitive Test Detects and Monitors Intact Virus Levels in COVID PatientsJanuary 22nd, 2025
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
